Cargando...
Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC
Non-small cell lung cancer (NSCLC) represents the paradigm of personalized treatment of human cancer. Several oncogenic druggable alterations have been so far identified, with anaplastic lymphoma kinase (ALK) gene rearrangements being one of the newest and most appealing. Presence of ALK fusions is...
Guardado en:
| Publicado en: | Transl Lung Cancer Res |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233871/ https://ncbi.nlm.nih.gov/pubmed/28149753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.12.05 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|